Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H20BrClN6O3 |
Molecular Weight | 555.811 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=NC(Cl)=C(N1CC2=CC3=C(OC(=C3Br)C4=CC=CC=C4C5=NN=NN5)C=C2)C(O)=O
InChI
InChIKey=FIKYECRHLXONOX-UHFFFAOYSA-N
InChI=1S/C24H20BrClN6O3/c1-2-3-8-18-27-22(26)20(24(33)34)32(18)12-13-9-10-17-16(11-13)19(25)21(35-17)14-6-4-5-7-15(14)23-28-30-31-29-23/h4-7,9-11H,2-3,8,12H2,1H3,(H,33,34)(H,28,29,30,31)
Molecular Formula | C24H20BrClN6O3 |
Molecular Weight | 555.811 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. | 1992 Dec |
|
Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics. | 1999 Jul |
|
Pharmacological properties of angiotensin II receptor antagonists. | 1999 Nov |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9088589
10 mg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:50:02 GMT 2023
by
admin
on
Fri Dec 15 15:50:02 GMT 2023
|
Record UNII |
6NA6UHB9SW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66930
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB00174MIG
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
72168
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
DTXSID70163156
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL304639
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
100000078813
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
149761
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
6NA6UHB9SW
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
C66702
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
7204
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
145781-32-4
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY | |||
|
149524
Created by
admin on Fri Dec 15 15:50:02 GMT 2023 , Edited by admin on Fri Dec 15 15:50:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|